These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

368 related articles for article (PubMed ID: 29446543)

  • 1. Cyclin dependent kinase inhibitor 2A/B gene deletions are markers of poor prognosis in Indian children with acute lymphoblastic leukemia.
    Agarwal M; Bakhshi S; Dwivedi SN; Kabra M; Shukla R; Seth R
    Pediatr Blood Cancer; 2018 Jun; 65(6):e27001. PubMed ID: 29446543
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic significance of CDKN2A/B deletions in acute lymphoblastic leukaemia: a meta-analysis.
    Zhang W; Kuang P; Liu T
    Ann Med; 2019 Feb; 51(1):28-40. PubMed ID: 30592434
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic significance of copy number alterations in adolescent and adult patients with precursor B acute lymphoblastic leukemia enrolled in PETHEMA protocols.
    Ribera J; Morgades M; Zamora L; Montesinos P; Gómez-Seguí I; Pratcorona M; Sarrà J; Guàrdia R; Nomdedeu J; Tormo M; Martínez-Lopez J; Hernández-Rivas JM; González-Campos J; Barba P; Escoda L; Genescà E; Solé F; Millá F; Feliu E; Ribera JM;
    Cancer; 2015 Nov; 121(21):3809-17. PubMed ID: 26194343
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CDKN2A/B alterations impair prognosis in adult BCR-ABL1-positive acute lymphoblastic leukemia patients.
    Iacobucci I; Ferrari A; Lonetti A; Papayannidis C; Paoloni F; Trino S; Storlazzi CT; Ottaviani E; Cattina F; Impera L; Abbenante MC; Vignetti M; Vitale A; Potenza L; Paolini S; Soverini S; Pane F; Luppi M; Foà R; Baccarani M; Martinelli G
    Clin Cancer Res; 2011 Dec; 17(23):7413-23. PubMed ID: 22134481
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deletion of CDKN2A/B is associated with inferior relapse free survival in pediatric B cell acute lymphoblastic leukemia.
    Kathiravan M; Singh M; Bhatia P; Trehan A; Varma N; Sachdeva MS; Bansal D; Jain R; Naseem S
    Leuk Lymphoma; 2019 Feb; 60(2):433-441. PubMed ID: 29966470
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CDKN2A, CDKN2B, and MTAP gene dosage permits precise characterization of mono- and bi-allelic 9p21 deletions in childhood acute lymphoblastic leukemia.
    Bertin R; Acquaviva C; Mirebeau D; Guidal-Giroux C; Vilmer E; Cavé H
    Genes Chromosomes Cancer; 2003 May; 37(1):44-57. PubMed ID: 12661005
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genomic CDKN2A/2B deletions in adult Ph
    Pfeifer H; Raum K; Markovic S; Nowak V; Fey S; Obländer J; Pressler J; Böhm V; Brüggemann M; Wunderle L; Hüttmann A; Wäsch R; Beck J; Stelljes M; Viardot A; Lang F; Hoelzer D; Hofmann WK; Serve H; Weiss C; Goekbuget N; Ottmann OG; Nowak D
    Blood; 2018 Mar; 131(13):1464-1475. PubMed ID: 29348129
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The prognostic significance of CDKN2A, CDKN2B and MTAP inactivation in B-lineage acute lymphoblastic leukemia of childhood. Results of the EORTC studies 58881 and 58951.
    Mirebeau D; Acquaviva C; Suciu S; Bertin R; Dastugue N; Robert A; Boutard P; Méchinaud F; Plouvier E; Otten J; Vilmer E; Cavé H;
    Haematologica; 2006 Jul; 91(7):881-5. PubMed ID: 16818274
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The correlation between Pax5 deletion and patients survival in Iranian children with precursor B-cell acute lymphocytic leukemia.
    Moafi A; Zojaji A; Salehi R; Najafi Dorcheh S; Rahgozar S
    Cell Mol Biol (Noisy-le-grand); 2017 Aug; 63(8):19-22. PubMed ID: 28886309
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Homozygous deletion of CDKN2A (p16, p14) and CDKN2B (p15) genes is a poor prognostic factor in adult but not in childhood B-lineage acute lymphoblastic leukemia: a comparative deletion and hypermethylation study.
    Kim M; Yim SH; Cho NS; Kang SH; Ko DH; Oh B; Kim TY; Min HJ; She CJ; Kang HJ; Shin HY; Ahn HS; Yoon SS; Kim BK; Shin HR; Han KS; Cho HI; Lee DS
    Cancer Genet Cytogenet; 2009 Nov; 195(1):59-65. PubMed ID: 19837270
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biallelic loss of CDKN2A is associated with poor response to treatment in pediatric acute lymphoblastic leukemia.
    Braun M; Pastorczak A; Fendler W; Madzio J; Tomasik B; Taha J; Bielska M; Sedek L; Szczepanski T; Matysiak M; Derwich K; Lejman M; Kowalczyk J; Kazanowska B; Badowska W; Styczynski J; Irga-Jaworska N; Trelinska J; Zalewska-Szewczyk B; Pierlejewski F; Wlodarska I; Młynarski W;
    Leuk Lymphoma; 2017 May; 58(5):1162-1171. PubMed ID: 27756164
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Frequency and clinical impact of CDKN2A/ARF/CDKN2B gene deletions as assessed by in-depth genetic analyses in adult T cell acute lymphoblastic leukemia.
    Genescà E; Lazarenkov A; Morgades M; Berbis G; Ruíz-Xivillé N; Gómez-Marzo P; Ribera J; Juncà J; González-Pérez A; Mercadal S; Guardia R; Artola MT; Moreno MJ; Martínez-López J; Zamora L; Barba P; Gil C; Tormo M; Cladera A; Novo A; Pratcorona M; Nomdedeu J; González-Campos J; Almeida M; Cervera J; Montesinos P; Batlle M; Vives S; Esteve J; Feliu E; Solé F; Orfao A; Ribera JM
    J Hematol Oncol; 2018 Jul; 11(1):96. PubMed ID: 30041662
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CDKN2B downregulation and other genetic characteristics in T-acute lymphoblastic leukemia.
    Jang W; Park J; Kwon A; Choi H; Kim J; Lee GD; Han E; Jekarl DW; Chae H; Han K; Yoon JH; Lee S; Chung NG; Cho B; Kim M; Kim Y
    Exp Mol Med; 2019 Jan; 51(1):1-15. PubMed ID: 30635552
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation between deletion of the CDKN2 gene and tyrosine kinase inhibitor resistance in adult Philadelphia chromosome-positive acute lymphoblastic leukemia.
    Xu N; Li YL; Li X; Zhou X; Cao R; Li H; Li L; Lu ZY; Huang JX; Fan ZP; Huang F; Zhou HS; Zhang S; Liu Z; Zhu HQ; Liu QF; Liu XL
    J Hematol Oncol; 2016 Apr; 9():40. PubMed ID: 27090891
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Yin and Yang-Like Clinical Implications of the
    González-Gil C; Ribera J; Ribera JM; Genescà E
    Genes (Basel); 2021 Jan; 12(1):. PubMed ID: 33435487
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deletion analysis of p16(INKa) and p15(INKb) in relapsed childhood acute lymphoblastic leukemia.
    Graf Einsiedel H; Taube T; Hartmann R; Wellmann S; Seifert G; Henze G; Seeger K
    Blood; 2002 Jun; 99(12):4629-31. PubMed ID: 12036898
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of CDKN2A/B deletions in pediatric acute lymphoblastic leukemia.
    Carrasco Salas P; Fernández L; Vela M; Bueno D; González B; Valentín J; Lapunzina P; Pérez-Martínez A
    Pediatr Hematol Oncol; 2016; 33(7-8):415-422. PubMed ID: 27960642
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular profiling refines minimal residual disease-based prognostic assessment in adults with Philadelphia chromosome-negative B-cell precursor acute lymphoblastic leukemia.
    Ribera J; Zamora L; Morgades M; Vives S; Granada I; Montesinos P; Gómez-Seguí I; Mercadal S; Guàrdia R; Nomdedeu J; Pratcorona M; Tormo M; Martínez-Lopez J; Hernández-Rivas JM; Ciudad J; Orfao A; González-Campos J; Barba P; Escoda L; Esteve J; Genescà E; Solé F; Feliu E; Ribera JM; ;
    Genes Chromosomes Cancer; 2019 Nov; 58(11):815-819. PubMed ID: 31340073
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence and clinical significance of CDKN2/MTS1/P16ink4A and MTS2/P15ink4B gene deletions in childhood acute lymphoblastic leukemia.
    Zhou M; Gu L; Yeager AM; Findley HW
    Pediatr Hematol Oncol; 1997; 14(2):141-50. PubMed ID: 9089742
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Homozygous deletions of cyclin-dependent kinase inhibitor genes, p16(INK4A) and p18, in childhood T cell lineage acute lymphoblastic leukemias.
    Iolascon A; Faienza MF; Coppola B; della Ragione F; Schettini F; Biondi A
    Leukemia; 1996 Feb; 10(2):255-60. PubMed ID: 8637234
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.